Covered recipient · General Payments record
JANICE DUTCHER
General Payments · PY2018–2024
$734,826.56
- Reported across 179 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $125,338.75 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $107,656.25 | 9 |
| Merck Sharp & Dohme Corporation | $14,182.50 | 2 |
| Iovance Biotherapeutics, Inc. | $3,500.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Daiichi Sankyo Inc. | $2,656.25 | 01/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089417852 | CMS |
| Daiichi Sankyo Inc. | $7,031.25 | 02/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089417842 | CMS |
| Daiichi Sankyo Inc. | $11,093.75 | 03/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089417846 | CMS |
| Daiichi Sankyo Inc. | $15,625.00 | 04/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089417850 | CMS |
| Daiichi Sankyo Inc. | $12,656.25 | 05/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089417840 | CMS |
| Daiichi Sankyo Inc. | $16,250.00 | 06/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089417844 | CMS |
| Daiichi Sankyo Inc. | $11,718.75 | 07/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089417856 | CMS |
| Daiichi Sankyo Inc. | $19,062.50 | 08/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089417848 | CMS |
| Daiichi Sankyo Inc. | $11,562.50 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089417854 | CMS |
| Iovance Biotherapeutics, Inc. | $3,500.00 | 05/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1147114364 | CMS |
| Merck Sharp & Dohme LLC | $5,795.00 | 05/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141604864 | CMS |
| Merck Sharp & Dohme LLC | $8,387.50 | 08/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141746275 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.